An explorative study on the interaction of cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1/ANRIL) gene polymorphism with obesity on periodontitis among Norwegian adults

Authors

  • Natalia Petrenya The Public Dental Health Service Competence Centre of Northern Norway, Tromsø, Norway
  • Laila A. Hopstock Department of Health and Care Sciences, UiT The Arctic University of Norway, Tromsø, Norway
  • Elin Hadler-Olsen The Public Dental Health Service Competence Centre of Northern Norway, Tromsø, Norway; Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway
  • Farah Asa'ad Department of Oral Biochemistry, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Lena Larsson Department of Oral Biochemistry, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Svetlana N. Zykova The Public Dental Health Service Competence Centre of Northern Norway, Tromsø, Norway; Center for Research and Education, University Hospital of North Norway, Tromsø, Norway; Hormone Laboratory, Department of Medical Biochemistry, Biochemical Endocrinology and Metabolism Research Group, Oslo University Hospital, Oslo, Norway
  • Gro Eirin Holde The Public Dental Health Service Competence Centre of Northern Norway, Tromsø, Norway; Department of Clinical Dentistry, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway
  • Alexandre R Vieira School of Dental Medicine, East Carolina University, Greenville, NC, USA
  • Birgitta Jönsson The Public Dental Health Service Competence Centre of Northern Norway, Tromsø, Norway; Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

DOI:

https://doi.org/10.2340/aos.v84.44368

Keywords:

periodontitis, obesity, ANRIL long non-coding RNA, single nucleotide polymorphism, genetic variation

Abstract

Objective ANRIL is a pleiotropic gene with a strong link to periodontitis. ANRIL gene variant rs1537373 is associated with altered CDKN2B gene expression, which is linked to obesity. In this explorative, cross-sectional population-based study, we aimed to investigate the hypothesis that ANRIL (rs1537373) T>G may be associated with periodontitis through interactions, focusing on rs1537373×obesity interaction.

Methods Genotyping for ANRIL (rs1537373), and clinical and periodontal examination were performed in 3554 participants (aged 40-93 years, 52% women) from the seventh survey of the Tromsø Study (2015–2016), Norway. We defined periodontitis stage based on radiographic bone loss (2018 AAP/EFP classification).

Results The individual association between rs1537373 and periodontitis, as well as multiplicative and additive interactions between rs1537373 and age, sex, smoking, and obesity on periodontitis under a recessive model were studied. We found multiplicative and additive interactions between rs1537373 and obesity. When compared with GT/TT genotype and no obesity, GG genotype and obesity was associated with higher odds for periodontitis stage III-IV (OR=2.47, 95%CI=1.48-4.12, p=0.001; relative excess risk due to interaction=1.51, 95%CI=0.26-2.77, p=0.018; attributable proportion due to interaction=0.61; 95%CI=0.35-0.87, p<0.001).

Conclusion Our findings suggest that rs1537373 GG genotype and obesity were jointly associated with periodontitis stage III-IV in this Norwegian population.

Downloads

Download data is not yet available.

References

Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89(Suppl. 1):S173–82.

Arboleda S, Vargas M, Losada S, Pinto A. Review of obesity and periodontitis: an epidemiological view. Br Dent J. 2019;227:235–239. https://doi.org/10.1038/s41415-019-0611-1 DOI: https://doi.org/10.1038/s41415-019-0611-1

Jepsen S, Suvan J, Deschner J. The association of periodontal diseases with metabolic syndrome and obesity. Periodontology 2000. 2020;83:125–53. https://doi.org/10.1111/prd.12326 DOI: https://doi.org/10.1111/prd.12326

Rahman B, Al-Marzooq F, Saad H, Benzina D, Al Kawas S. Dysbiosis of the subgingival microbiome and relation to periodontal disease in association with obesity and overweight. Nutrients 2023;15:826. https://doi.org/10.3390/nu15040826 DOI: https://doi.org/10.3390/nu15040826

Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177–85. https://doi.org/10.1038/nature21363 DOI: https://doi.org/10.1038/nature21363

Zhu M, Nikolajczyk BS. Immune cells link obesity-associated type 2 diabetes and periodontitis. J Dent Res. 2014;93:346–52. https://doi.org/10.1177/0022034513518943 DOI: https://doi.org/10.1177/0022034513518943

Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126:1549–64. https://doi.org/10.1161/CIRCRESAHA.119.315896 DOI: https://doi.org/10.1161/CIRCRESAHA.119.315896

Savini I, Gasperi V, Catani MV. Oxidative stress and obesity. In: Ahmad SI, Imam SK, editors. Obesity: a practical guide. Cham: Springer International Publishing; 2016. p. 65–86. DOI: https://doi.org/10.1007/978-3-319-19821-7_6

Kwack KH, Zhang L, Sohn J, Maglaras V, Thiyagarajan R, Kirkwood KL. Novel preosteoclast populations in obesity-associated periodontal disease. J Dent Res. 2022;101:348–56. https://doi.org/10.1177/00220345211040729 DOI: https://doi.org/10.1177/00220345211040729

Yoshihara A, Kaneko N, Nohno K, Iwasaki M. Interaction between beta-3 adrenergic receptor genotype and environmental factors on periodontal progression. J Clin Periodontol. 2019;46:623–30. https://doi.org/10.1111/jcpe.13115 DOI: https://doi.org/10.1111/jcpe.13115

Wilkins LM, Kaye EK, Wang HY, Rogus J, Doucette-Stamm L, Kornman K, et al. Influence of obesity on periodontitis progression is conditional on interleukin-1 inflammatory genetic variation. J Periodontol. 2017;88:59–68. https://doi.org/10.1902/jop.2016.160408 DOI: https://doi.org/10.1902/jop.2016.160408

Yoshihara A, Sugita N, Iwasaki M, Miyazaki H, Nakamura K. The interaction between beta-3 adrenergic receptor polymorphism and obesity to periodontal disease in community-dwelling elderly Japanese. J Clin Periodontol. 2014;41:460–6. https://doi.org/10.1111/jcpe.12235 DOI: https://doi.org/10.1111/jcpe.12235

Ozturk A, Ada A. The roles of ANRIL polymorphisms in periodontitis: a systematic review and meta-analysis. Clin Oral Investig. 2022;26:1121–35. https://doi.org/10.1007/s00784-021-04257-0 DOI: https://doi.org/10.1007/s00784-021-04257-0

Bochenek G, Häsler R, El Mokhtari NE, König IR, Loos BG, Jepsen S, et al. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Hum Mol Genet. 2013;22:4516–27. https://doi.org/10.1093/hmg/ddt299 DOI: https://doi.org/10.1093/hmg/ddt299

Schaefer AS, Richter GM, Dommisch H, Reinartz M, Nothnagel M, Noack B, et al. CDKN2BAS is associated with periodontitis in different European populations and is activated by bacterial infection. J Med Genet. 2011;48:38–47. https://doi.org/10.1136/jmg.2010.078998 DOI: https://doi.org/10.1136/jmg.2010.078998

Aarabi G, Zeller T, Seedorf H, Reissmann DR, Heydecke G, Schaefer AS, et al. Genetic susceptibility contributing to periodontal and cardiovascular disease. J Dent Res. 2017;96:610–17. https://doi.org/10.1177/0022034517699786 DOI: https://doi.org/10.1177/0022034517699786

Aarabi G, Zeller T, Heydecke G, Munz M, Schäfer A, Seedorf U. Roles of the Chr.9p21.3 ANRIL locus in regulating inflammation and implications for anti-inflammatory drug target identification. Front Cardiovasc Med. 2018;5:47. https://doi.org/10.3389/fcvm.2018.00047 DOI: https://doi.org/10.3389/fcvm.2018.00047

Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, El Mokhtari NE, et al. Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet. 2009;5:e1000378. https://doi.org/10.1371/journal.pgen.1000378 DOI: https://doi.org/10.1371/journal.pgen.1000378

Wang W, Yang Z, Wang Y, Gao H, Wang Y, Zhang Q. Association between periodontitis and carotid artery calcification: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:3278351. https://doi.org/10.1155/2021/3278351 DOI: https://doi.org/10.1155/2021/3278351

Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut. 2018;67:120–7. https://doi.org/10.1136/gutjnl-2016-312580 DOI: https://doi.org/10.1136/gutjnl-2016-312580

Nepomuceno R, Pigossi SC, Finoti LS, Orrico SRP, Cirelli JA, Barros SP, et al. Serum lipid levels in patients with periodontal disease: a meta-analysis and meta-regression. J Clin Periodontol. 2017;44:1192–207. https://doi.org/10.1111/jcpe.12792 DOI: https://doi.org/10.1111/jcpe.12792

Graham SE, Clarke SL, Wu KH, Kanoni S, Zajac GJM, Ramdas S, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600:675–9. https://doi.org/10.1038/s41586-021-04064-3 DOI: https://doi.org/10.1038/s41586-021-04064-3

Li Y, Zhang D, Zhang Y, Xu X, Bi L, Zhang M, et al. Association of lncRNA polymorphisms with triglyceride and total cholesterol levels among myocardial infarction patients in Chinese population. Gene. 2020;724:143684. https://doi.org/10.1016/j.gene.2019.02.085 DOI: https://doi.org/10.1016/j.gene.2019.02.085

Pechlivanis S, Mühleisen TW, Möhlenkamp S, Schadendorf D, Erbel R, Jöckel KH, et al. Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study. BMC Med Genet. 2013;14:23. https://doi.org/10.1186/1471-2350-14-23 DOI: https://doi.org/10.1186/1471-2350-14-23

Zhu B, Zhu Y, Tian J, Shen N, Li J, Lou J, et al. A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. Mol Carcinog. 2019;58:760–6. https://doi.org/10.1002/mc.22968 DOI: https://doi.org/10.1002/mc.22968

Liu Y, Zhu ZX, Zboinski EK, Qiu W, Lian J, Liu S, et al. Long non-coding RNA APDC plays important regulatory roles in metabolism of bone and adipose tissues. RNA Biol. 2023;20:836–46. https://doi.org/10.1080/15476286.2023.2268489 DOI: https://doi.org/10.1080/15476286.2023.2268489

Meseure D, Vacher S, Alsibai KD, Nicolas A, Chemlali W, Caly M, et al. Expression of ANRIL-polycomb complexes-CDKN2A/B/ARF genes in breast tumors: identification of a two-gene (EZH2/CBX7) signature with independent prognostic value. Mol Cancer Res. 2016;14: 623–33. https://doi.org/10.1158/1541-7786.MCR-15-0418 DOI: https://doi.org/10.1158/1541-7786.MCR-15-0418

Miller CL, Pjanic M, Wang T, Nguyen T, Cohain A, Lee JD, et al. Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci. Nat Commun. 2016;7:12092. https://doi.org/10.1038/ncomms12092 DOI: https://doi.org/10.1038/ncomms12092

Ali MW, Patro CPK, Devall M, Dampier CH, Plummer SJ, Kuscu C, et al. A functional variant on 9p21.3 related to glioma risk affects enhancer activity and modulates expression of CDKN2B-AS1. Hum Mutat. 2021;42:1208–14. https://doi.org/10.1002/humu.24244 DOI: https://doi.org/10.1002/humu.24244

Horswell SD, Fryer LG, Hutchison CE, Zindrou D, Speedy HE, Town MM, et al. CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients. J Lipid Res. 2013;54:3491–505. https://doi.org/10.1194/jlr.M041814 DOI: https://doi.org/10.1194/jlr.M041814

Svensson PA, Wahlstrand B, Olsson M, Froguel P, Falchi M, Bergman RN, et al. CDKN2B expression and subcutaneous adipose tissue expandability: possible influence of the 9p21 atherosclerosis locus. Biochem Biophys Res Commun. 2014;446:1126–31. https://doi.org/10.1016/j.bbrc.2014.03.075 DOI: https://doi.org/10.1016/j.bbrc.2014.03.075

Kahoul Y, Oger F, Montaigne J, Froguel P, Breton C, Annicotte JS. Emerging roles for the INK4a/ARF (CDKN2A) locus in adipose tissue: Implications for obesity and type 2 diabetes. Biomolecules 2020;10:1350. https://doi.org/10.3390/biom10091350 DOI: https://doi.org/10.3390/biom10091350

Lillycrop K, Murray R, Cheong C, Teh AL, Clarke-Harris R, Barton S, et al. ANRIL promoter DNA methylation: a perinatal marker for later adiposity. EBioMedicine. 2017;19:60–72. https://doi.org/10.1016/j.ebiom.2017.03.037 DOI: https://doi.org/10.1016/j.ebiom.2017.03.037

Curtis EM, Murray R, Titcombe P, Cook E, Clarke-Harris R, Costello P, et al. Perinatal DNA methylation at CDKN2A is associated with offspring bone mass: findings from the Southampton Women’s Survey. J Bone Miner Res. 2017;32:2030–40. https://doi.org/10.1002/jbmr.3153 DOI: https://doi.org/10.1002/jbmr.3153

Chen L, Qu H, Guo M, Zhang Y, Cui Y, Yang Q, et al. ANRIL and atherosclerosis. J Clin Pharm Ther. 2020;45:240–8. https://doi.org/10.1111/jcpt.13060 DOI: https://doi.org/10.1111/jcpt.13060

Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet. 2008;17:806–14. https://doi.org/10.1093/hmg/ddm352 DOI: https://doi.org/10.1093/hmg/ddm352

Sanyal N, Napolioni V, de Rochemonteix M, Belloy ME, Caporaso NE, Landi MT, et al. A robust test for additive gene-environment interaction under the trend effect of genotype using an empirical bayes-type shrinkage estimator. Am J Epidemiol. 2021;190:1948–60. https://doi.org/10.1093/aje/kwab124 DOI: https://doi.org/10.1093/aje/kwab124

Hopstock LA, Grimsgaard S, Johansen H, Kanstad K, Wilsgaard T, Eggen AE. The seventh survey of the Tromsø Study (Tromsø7) 2015–2016: study design, data collection, attendance, and prevalence of risk factors and disease in a multipurpose population-based health survey. Scand J Public Health. 2022;50:919–29. https://doi.org/10.1177/14034948221092294 DOI: https://doi.org/10.1177/14034948221092294

Holde GE, Bunæs DF, Jönsson B. Comparison between the 2017 EFP/AAP and CDC/AAP case definitions on periodontal status and their association with risk factors in an adult Norwegian population-insights from the Tromsø study: Tromsø7. Int J Dent Hyg 2025. https://doi.org/10.1111/idh.12909 DOI: https://doi.org/10.1111/idh.12909

Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl. 1):S159–72. https://doi.org/10.1002/JPER.18-0006 DOI: https://doi.org/10.1002/JPER.18-0006

Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions – introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45(Suppl. 20):S1–8. https://doi.org/10.1111/jcpe.12935 DOI: https://doi.org/10.1111/jcpe.12935

Asa’ad F, Petrenya N, Jönsson B, Holde GE, Oscarson N, Hadler-Olsen E, et al. Polymorphism in epigenetic regulating genes in relation to periodontitis, number of teeth, and levels of high-sensitivity C-reactive protein and glycated hemoglobin: the Tromsø study 2015–2016. J Periodontol. 2023;94(11):1324–37. https://doi.org/10.1002/JPER.23-0108 DOI: https://doi.org/10.1002/JPER.23-0108

Hannou SA, Wouters K, Paumelle R, Staels B. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? Trends Endocrinol Metab. 2015;26:176–84. https://doi.org/10.1016/j.tem.2015.01.008 DOI: https://doi.org/10.1016/j.tem.2015.01.008

Eibl G, Rozengurt E. Obesity and pancreatic cancer: insight into mechanisms. Cancers. 2021;13:5067. https://doi.org/10.3390/cancers13205067 DOI: https://doi.org/10.3390/cancers13205067

Jensen JC, Dardari ZA, Blaha MJ, White S, Shaw LJ, Rumberger J, et al. Association of body mass index with coronary artery calcium and subsequent cardiovascular mortality. Circ Cardiovasc Imaging. 2020;13:e009495. https://doi.org/10.1161/CIRCIMAGING.119.009495 DOI: https://doi.org/10.1161/CIRCIMAGING.119.009495

Feingold KR. Obesity and dyslipidemia. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al., editors. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000.

Grimby G, Börjesson M, Jonsdottir IH, Schnohr P, Thelle DS, Saltin B. The ‘Saltin–Grimby Physical Activity Level Scale’ and its application to health research. Scand J Med Sci Sports. 2015;25:119–25. https://doi.org/10.1111/sms.12611 DOI: https://doi.org/10.1111/sms.12611

Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9. https://doi.org/10.1007/s10654-005-7835-x DOI: https://doi.org/10.1007/s10654-005-7835-x

Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452–6. https://doi.org/10.1097/00001648-199209000-00012 DOI: https://doi.org/10.1097/00001648-199209000-00012

Dietrich T, Ower P, Tank M, West NX, Walter C, Needleman I, et al. Periodontal diagnosis in the context of the 2017 classification system of periodontal diseases and conditions – implementation in clinical practice. Br Dent J. 2019;226:16–22. https://doi.org/10.1038/sj.bdj.2019.3 DOI: https://doi.org/10.1038/sj.bdj.2019.3

Kurokawa N, Young EH, Oka Y, Satoh H, Wareham NJ, Sandhu MS, et al. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond). 2008;32:1240–9. https://doi.org/10.1038/ijo.2008.90 DOI: https://doi.org/10.1038/ijo.2008.90

Ryuk JA, Zhang X, Ko BS, Daily JW, Park S. Association of β3-adrenergic receptor rs4994 polymorphisms with the risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2017;129:86–96. https://doi.org/10.1016/j.diabres.2017.03.034 DOI: https://doi.org/10.1016/j.diabres.2017.03.034

Keller A, Rohde JF, Raymond K, Heitmann BL. Association between periodontal disease and overweight and obesity: a systematic review. J Periodontol. 2015;86:766–76. https://doi.org/10.1902/jop.2015.140589 DOI: https://doi.org/10.1902/jop.2015.140589

Gerber FA, Sahrmann P, Schmidlin OA, Heumann C, Beer JH, Schmidlin PR. Influence of obesity on the outcome of non-surgical periodontal therapy – a systematic review. BMC Oral Health. 2016;16:90. https://doi.org/10.1186/s12903-016-0272-2 DOI: https://doi.org/10.1186/s12903-016-0272-2

Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, et al. Long non-coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020;10:598817. https://doi.org/10.3389/fonc.2020.598817 DOI: https://doi.org/10.3389/fonc.2020.598817

Wufuer A, Luohemanjiang X, Du L, Lei J, Shabier M, Han DF, et al. ANRIL overexpression globally induces expression and alternative splicing of genes involved in inflammation in HUVECs. Mol Med Rep. 2023;27:27. https://doi.org/10.3892/mmr.2022.12915 DOI: https://doi.org/10.3892/mmr.2022.12915

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–337. https://doi.org/10.1093/eurheartj/ehab484 DOI: https://doi.org/10.1093/eurheartj/ehab484

Tcheandjieu C, Zhu X, Hilliard AT, Clarke SL, Napolioni V, Ma S, et al. Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. Nat Med. 2022;28:1679–92. https://doi.org/10.1038/s41591-022-01891-3 DOI: https://doi.org/10.1038/s41591-022-01891-3

Li H, Han S, Sun Q, Yao Y, Li S, Yuan C, et al. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression. Aging (Albany NY). 2019;11:1695–715. https://doi.org/10.18632/aging.101863 DOI: https://doi.org/10.18632/aging.101863

Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96–118. https://doi.org/10.1038/s41580-020-00315-9 DOI: https://doi.org/10.1038/s41580-020-00315-9

Additional Files

Published

2025-08-14